Company news

Penumbra, Inc. news in 2025

Penumbra, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 29, 2025

Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

November 19, 2025

Penumbra, Inc. Reports Third Quarter 2025 Financial Results

November 5, 2025

Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism

November 3, 2025

Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism

October 27, 2025

Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025

October 8, 2025

Penumbra, Inc. Names Shruthi Narayan as Company President

August 27, 2025

Penumbra, Inc. to Present at Upcoming Investor Conferences

August 20, 2025

Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

July 30, 2025

Penumbra, Inc. Reports Second Quarter 2025 Financial Results

July 29, 2025

Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

July 1, 2025

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

June 16, 2025

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

June 5, 2025

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

April 29, 2025

Penumbra, Inc. Reports First Quarter 2025 Financial Results

April 23, 2025

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

April 3, 2025

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

April 2, 2025

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

February 21, 2025

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

February 18, 2025

Calls in 2025

Decks in 2025